Dana L. Jacoby - 13 May 2025 Form 4 Insider Report for biote Corp. (BTMD)

Role
Director
Signature
/s/ Marybeth Conlon, as Attorney-in-Fact for Dana L. Jacoby
Issuer symbol
BTMD
Transactions as of
13 May 2025
Net transactions value
$0
Form type
4
Filing time
14 May 2025, 19:42:22 UTC
Previous filing
23 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jacoby Dana Lynn Director C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING /s/ Marybeth Conlon, as Attorney-in-Fact for Dana L. Jacoby 14 May 2025 0001931319

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTMD Class A Common Stock Options Exercise +12,994 +25% 63,964 13 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTMD Deferred Settlement RSU Options Exercise $0 -12,994 -100% $0.000000 0 13 May 2025 Class A Common Stock 12,994 Direct F1, F2
transaction BTMD Deferred Settlement RSU Award $0 +21,587 $0.000000 21,587 13 May 2025 Class A Common Stock 21,587 Direct F1, F3
transaction BTMD Stock Option (Right to Buy) Award $0 +104,547 $0.000000 104,547 13 May 2025 Class A Common Stock 104,547 $3.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
F2 The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
F3 The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.
F4 All shares subject to the option award shall vest on the earlier of May 13, 2026 or the day prior to the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.